Experimentation at small scale is crucial for the cost-efficient development of bioprocesses, which then can be transferred to larger volumes. We have proven the feasibility of ATF-based perfusion using the DASGIP Parallel Bioreactor System.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Perfusion Using an ATF Cell Retention Device
Related Resources
Discover the world of upstream bioprocessing
A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.
Manufacturing of hiPSC-Derived Cardiomyocytes
Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent stem cells (hiPSC) hold great promise to overcome this challenge. In this application note...
Supplier Info Centre
For more product information visit Eppendorf Bioprocess Solutions.